— medmix at a glance — Our key figures
Our key figures
Our revenue increased by 5.7% (5.7% organically). We delivered profitability of 22.1% adjusted EBITDA margin and a free cash flow of CHF 10.3 million.
Share of revenue by market segment
2022
Share of revenue by market segment
2021
Key figures
|
millions of CHF |
|
2022 |
|
2021 |
|
Change in +/–% |
|
+/–% adjusted 1) |
|
+/–% organic 2) |
|
Revenue |
|
477.1 |
|
457.3 |
|
4.3 |
|
5.7 |
|
5.7 |
|
Gross profit |
|
175.4 |
|
181.2 |
|
–3.2 |
|
|
|
|
|
Operating income (EBIT) |
|
19.6 |
|
59.9 |
|
–67.3 |
|
|
|
|
|
EBITDA |
|
70.7 |
|
111.7 |
|
–36.7 |
|
|
|
|
|
Adjusted EBITDA |
|
105.4 |
|
114.5 |
|
–7.9 |
|
|
|
|
|
Adjusted EBITDA margin |
|
22.1% |
|
25.0% |
|
|
|
|
|
|
|
Net income attributable to shareholders of medmix Ltd |
|
11.6 |
|
44.0 |
|
–73.7 |
|
|
|
|
|
Basic earnings per share (in CHF) |
|
0.28 |
|
1.07 |
|
–73.6 |
|
|
|
|
|
Free cash flow (FCF) |
|
10.3 |
|
55.6 |
|
–81.4 |
|
|
|
|
|
Net debt as of December 31 |
|
156.7 |
|
110.9 |
|
41.3 |
|
|
|
|
|
Employees (number of full-time equivalents) as of December 31 |
|
2’067 |
|
2’036 |
|
1.5 |
|
|
|
|
1) Adjusted for currency effects.
2) Adjusted for acquisition and currency effects.
Our KEY Figures
revenue in 2022
adjusted EBITDA margin
free cash flow generated in 2022
Stock market information
|
|
|
2022 |
|
2021 |
|
|
|
|
Registered share (in CHF) |
|
|
|
|
|
|
|
|
– high |
|
47.00 |
|
48.44 |
|
|
|
|
– low |
|
15.70 |
|
41.00 |
|
|
|
|
– year-end |
|
17.60 |
|
45.16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Market capitalization as of December 31 |
|
|
|
|
|
|
|
|
– number of shares issued |
|
41’262’370 |
|
41’262’370 |
|
|
|
|
– in millions of CHF |
|
726 |
|
1’863 |
|
|
|
|
– in percentage of equity |
|
144% |
|
349% |
|
|
|
|
|
|
|
|
|
|
|
|
|
P/E ratio as of December 31 |
|
62.4x |
|
42.2x |
|
|
|
|
Dividend yield as of December 31 |
|
2.8% |
|
1.1% |
|
|
|
Data per share
|
CHF |
|
2022 |
|
2021 |
|
|
|
|
Net income attributable to a shareholder of medmix Ltd |
|
0.28 |
|
1.07 |
|
|
|
|
Equity attributable to a shareholder of medmix Ltd |
|
12.20 |
|
12.90 |
|
|
|
|
Ordinary dividend |
|
0.50 1) |
|
0.50 |
|
|
|
|
Payout ratio |
|
177% |
|
47% |
|
|
|
|
Average number of shares outstanding |
|
40’957’744 |
|
41’161’439 |
|
|
|
1) Proposal to the Annual General Meeting.
Shareholder structure as per December 31, 2022
|
Number of shares |
|
Number of shareholders |
|
Shareholding |
|
1–100 |
|
3’127 |
|
0.4% |
|
101–1’000 |
|
4’677 |
|
4.2% |
|
1’001–10’000 |
|
743 |
|
4.9% |
|
10’001–100’000 |
|
91 |
|
5.8% |
|
More than 100’000 |
|
23 |
|
55.1% |
|
Total registered shareholders and shares (excluding treasury shares medmix Ltd) |
|
8’661 |
|
70.4% |
Shareholder structure as per December 31, 2021
|
Number of shares |
|
Number of shareholders |
|
Shareholding |
|
1–100 |
|
3’615 |
|
0.5% |
|
101–1’000 |
|
4’970 |
|
4.2% |
|
1’001–10’000 |
|
651 |
|
4.3% |
|
10’001–100’000 |
|
69 |
|
5.1% |
|
More than 100’000 |
|
19 |
|
52.7% |
|
Total registered shareholders and shares (excluding treasury shares medmix Ltd) |
|
9’324 |
|
66.8% |